Precision medicine and mutation detection advances in CLL
The basis for immunotherapy in multiple myeloma
Ignacio Melero Bermejo
The differences in treating older versus younger CLL patients
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax